Health

Rheumatoid arthritis is a chronic autoimmune disease that not only affects the joints but also increases the risk of cardiovascular events and mortality. Previous studies have shown that conventional risk factors are not sufficient to predict major adverse cardiovascular events (MACE) and mortality in rheumatoid arthritis patients. Factors such as smoking, obesity, hypertension, and even
A recent study has shed light on the lost opportunities to provide adequate treatment for drug overdose survivors who are covered by the Medicare program. The study highlights the challenges in managing chronic pain among this vulnerable population. According to Dr. Brian Hurley, president of the American Society of Addiction Medicine, overdose survivors should have
The FDA recently approved two new immunotherapy-chemotherapy options for patients with primary advanced or recurrent endometrial cancer. The first option is the PD-1-directed immune checkpoint inhibitor pembrolizumab (Keytruda), which is approved in combination with carboplatin and paclitaxel for patients with either mismatch repair (MMR)-deficient or MMR-proficient disease. The approval was based on the promising results
Dean Ornish, MD, claims that the only side effects of an intensive lifestyle intervention for early Alzheimer’s disease are good ones. While this may sound promising, it is essential to critically analyze the validity of such a statement. Is it truly possible for any medical intervention to have only positive side effects, without any potential
Patients with axial spondyloarthritis (axSpA) are accustomed to regular follow-up appointments in order to manage their condition effectively. However, a recent randomized trial conducted by Dr. Inger Jorid Berg and her team at Diakonhjemmet Hospital in Oslo, Norway, revealed that patients who initiated follow-up contacts with their clinicians actually fared no worse medically compared to
The issue of air pollution is not limited to its impact on the environment; it also poses a significant threat to human health, especially for expectant mothers. Recent studies have highlighted the alarming connection between maternal exposure to particulate matter (PM) and adverse pregnancy outcomes, particularly in relation to blood pressure complications. These findings shed
The study conducted by Dr. Erminia Massarelli, MD, PhD, focused on evaluating the effectiveness of osimertinib (Tagrisso) in combination with consolidative stereotactic ablative radiation (SABR) for treating advanced EGFR-mutant non-small cell lung cancer (NSCLC). This trial was presented at the American Society of Clinical Oncology (ASCO) meeting and aimed to determine the impact of this